The goal of precision medicine is to deliver the right treatment at the right time to the right patient. To achieve better-tailored medicine, therapies must be developed not for the average person (the aggregate population) but with consideration of the varied nature of the individual and their disease.
This eSeminar, “Latest Trends in Precision Medicine,” will bring together Beckman Coulter Life Sciences, Leica Microsystem, Leica Biosystems, Phenomenex, Pall Corporation, Integrated DNA Technologies, and SCIEX, all from Danaher’s Life Sciences division, plus Beckman Coulter Diagnostics, to share the latest innovations and tools for precision medicines that accelerate your research.